- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,054,674
- Total 13F shares
- 10,225,954
- Share change
- +8,865
- Total reported value
- $41,413,000
- Price per share
- $4.05
- Number of holders
- 20
- Value change
- -$249,669
- Number of buys
- 13
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 50127T109:
Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.6%
|
3,113,719
|
$26,155,000 | — | 31 Dec 2015 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.8%
|
2,450,000
|
$20,580,000 | — | 31 Dec 2015 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.7%
|
1,494,169
|
$12,551,000 | — | 31 Dec 2015 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
1.2%
|
1,087,233
|
$9,133,000 | — | 31 Dec 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.1%
|
970,171
|
$8,149,000 | — | 31 Dec 2015 | |
| Boxer Capital, LLC |
13F
|
Company |
0.75%
|
654,595
|
$5,499,000 | — | 31 Dec 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.26%
|
225,667
|
$1,896,000 | — | 31 Dec 2015 | |
| Birchview Capital, LP |
13F
|
Company |
0.12%
|
105,285
|
$884,000 | — | 31 Dec 2015 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.07%
|
65,222
|
$548,000 | — | 31 Dec 2015 | |
| Partner Investment Management, L.P. |
13F
|
Company |
0.06%
|
48,748
|
$409,000 | — | 31 Dec 2015 | |
| Kiski Partners, LLC |
13F
|
Company |
0.03%
|
29,780
|
$250,000 | — | 31 Dec 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,022
|
$9,000 | — | 31 Dec 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
858
|
$7,000 | — | 31 Dec 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
400
|
$3,000 | — | 31 Dec 2015 |
Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q1 2016
As of 31 Mar 2016,
Kura Oncology, Inc. - Common Stock (KURA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,225,954 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., CLOUGH CAPITAL PARTNERS L P, FRANKLIN RESOURCES INC, Boxer Capital, LLC, VANGUARD GROUP INC, Monashee Investment Management LLC, Birchview Capital, LP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2016 vs Q4 2015 Across Filers
Q4 2015 holders
14
Q1 2016 holders
20
Holder diff
6
| Investor | Q4 2015 Shares | Q1 2016 Shares | Share Diff | Share Chg % | Q4 2015 Value $ | Q1 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.